Academic Editor

Article Metrics

  • Fig. 1.

    View in Article
    Full Image
  • Fig. 2.

    View in Article
    Full Image
  • Fig. 3.

    View in Article
    Full Image
  • Fig. 4.

    View in Article
    Full Image
  • Fig. 5.

    View in Article
    Full Image
  • Information

  • Download

  • Contents

Abstract

Background:

The progression of myopia is typically accompanied by hypoxia-induced remodeling of the scleral extracellular matrix (ECM). In this study, we focused on the regulatory mechanisms underlying Notch signaling pathway activation of mitochondrial dynamics under conditions of scleral hypoxia, along with its effects on the scleral ECM.

Methods:

Three-week-old male guinea pigs were used to establish form-deprived myopia (FDM) models, and human scleral fibroblasts (HSFs) were cultured in a hypoxic environment. To examine the intrinsic associations among factors, we used short hairpin RNAs (shRNAs) to independently knock down hypoxia-inducible factor alpha (HIF-1α) and Notch1. Expression of key molecules was assessed by western blotting, quantitative real-time polymerase chain reaction (qPCR), and immunofluorescence (IF) analyses. Additionally, mitochondrial morphology, membrane potential (ΔΨm), and reactive oxygen species (ROS) levels were assessed, and the specific dynamin-related protein 1 (DRP1) inhibitor Mdivi-1 was used to determine its regulatory effects on scleral ECM.

Results:

In the FDM model, we detected a marked upregulation of scleral HIF-1α and Notch1, along with abnormal mitochondrial fission and ECM remodeling. Hypoxia-cultured HSFs were found to be characterized by mitochondrial fragmentation, a reduction in ΔΨm, elevated levels of ROS and α-smooth muscle actin (α-SMA), and a reduction in type I collagen [markers indicative of fibroblast-myofibroblast transition (FMT) and ECM remodeling]. Notably, we observed that knockdown of HIF-1α was associated with a reduction in Notch1 levels, and a subsequent knockdown of Notch1 inhibited the expression of DRP1 and attenuated abnormal mitochondrial fission. Furthermore, pharmacological inhibition of mitochondrial fission using Mdivi-1 contributed to an amelioration of the aberrant mitochondrial morphology and reduced the expression of FMT markers in vitro.

Conclusion:

Collectively, our findings indicate a potential link between scleral hypoxia and mitochondrial fragmentation, which may involve activation of Notch1 signaling and subsequent changes in the composition of the scleral ECM. In vitro, inhibition of mitochondrial fission appeared to mitigate the transformation of human scleral fibroblasts toward a myofibroblast-like phenotype. These findings provide evidence of a novel hypoxia-associated cellular pathway that warrants further investigation to establish its causal role and therapeutic relevance in myopic scleral remodeling.

1. Introduction

The prevalence of myopia continues to increase globally. According to the report released by the World Health Organization, the prevalence of myopia among adolescents the incidence of myopia exceeds 60%, and is projected to affect 10% of the global population [1, 2]. Notably, high myopia-induced visual impairment accordingly represents a major public health challenge. The core pathological change is the excessive elongation of the axial length, while the sclera in high myopic individuals typically presents structural anomalies [3]. However, despite extensive research on the pathogenesis of high myopia, the precise underlying molecular mechanisms have yet to be sufficiently determined.

Clinical investigations have revealed that the choroidal thickness in patients with high myopia is approximately 50% less than that in healthy individuals [4, 5, 6]. This substantial choroidal thinning leads to an insufficient oxygen supply to the sclera through the choroidal blood vessels, with subsequent establishment of a hypoxic microenvironment [7]. This process contributes to the thinning of the sclera and ultimately promotes the progressive elongation of the eye axis [8]. The core components of the sclera are the extracellular matrix (ECM), comprising large amounts of type I collagen and the fibroblasts responsible for secreting the ECM, the latter being the primary cell type maintaining tissue homeostasis [9, 10]. Key changes in high myopia development involve a reduction in the contents of type I collagen and an accelerated transition from fibroblasts to myofibroblasts (FMT). These changes contribute to a disruption of scleral homeostasis, leading to abnormal ECM remodeling, scleral thinning, and excessive axial elongation, thereby accelerating the progression of myopia [11]. Given the high energy dependence of these processes, the mitochondria are assumed to play a pivotal role in the pathogenesis, although the association between scleral mitochondrial dysfunction and the development of myopia has yet to be sufficiently established.

The morphology and intracellular distribution of the mitochondria are dynamically regulated via continuous fusion and fission processes, which are regulated by mitochondrial fusion proteins (MFNs) and dynamin-related protein 1 (DRP1) [12, 13]. Notably, excessive mitochondrial fission significantly promotes the accumulation of reactive oxygen species (ROS) within cells [14], and can lead to cellular dysfunction, abnormal differentiation, and other issues [12, 15, 16]. The findings of previous studies have indicated that the Notch signaling pathway actively regulates cellular energy homeostasis [17]. Also modulates mitochondrial energy metabolism in different diseases. For instance, the activation of Notch has been shown to stimulates mitochondrial fission in gastric and breast cancer cells [18, 19]. In addition to Notch signaling, hypoxia plays a pivotal role in the occurrence of mitochondrial dysfunction [20].

In this study, we demonstrated that mitochondrial fission plays a key role in scleral remodeling during myopia. Our findings indicate that by activating the Notch1 signaling pathway, scleral hypoxia induces mitochondrial fragmentation, thereby promoting a remodeling of the scleral ECM. In addition, we established that inhibition of mitochondrial fission suppresses the transformation of human scleral fibroblasts (HSFs) to myofibroblasts. By revealing the role of mitochondrial dynamics in remodeling of the scleral ECM, these findings contribute to a more comprehensive understanding of scleral energy metabolism in myopia and thereby provide valuable insights into the mechanisms underlying the development of this visual disorder.

2. Method
2.1 Animals

The guinea pigs used in this study were obtained from Keda (Tianjin, China) and housed in a standard laboratory setting under a 12-hour light/dark cycle and provided with a standard diet. All experimental procedures were conducted with strict adherence to international ethical guidelines for the use of laboratory animals, and the study also received approval from the Medical Laboratory Animal Ethics Committee of Tianjin Medical University Eye Hospital (TJYY2024120244).

2.2 Establishment of the Guinea Pig Form-Deprived Myopia (FDM) Model

For the purposes of this study, we used healthy 3-week-old male guinea pigs. Pre-experimentally, those with ocular diseases or anisometropia >1.50D were excluded after screening and the remaining animals were randomly assigned to either a control (CON) or form-deprived myopia (FDM) group. Whereas animals in the CON group received no ocular treatment, the right eyes of guinea pigs in the FDM group were completely covered with a white latex balloon helmet (the left eye, ears, nose, and mouth remained exposed), with daily inspections being conducted to ensure effective coverage. All animals were housed under standard conditions (12 h light/dark cycle) and subjected to biweekly refraction and axial length measurements. After 6 weeks, the scleral tissues were collected for histopathological and related biological analyses.

2.3 Axial Length Measurement

Axial length, defined as the distance from the anterior corneal apex to the anterior retinal surface, was measured using an A-mode ultrasonic ophthalmoscope (A-scan, ODM-1000A; Tianjin Medatech Co., Ltd., Tianjin, China). Prior to measurement, a drop of 0.5% Proparacaine Hydrochloride Eye Drops (Alcon, Mechelen, Belgium) was instilled into the conjunctival sac of the guinea pigs for topical anesthesia. Subsequently, the probe of the ophthalmoscope was placed vertically on the apex of the guinea pig cornea and aligned with the center of the pupil for measurement, thereby obtaining stable waveform data. For each eye, we performed five measurements, with average values being recorded.

2.4 Refraction Measurement

Refractive error was measured using an infrared auto-refractometer (Photorefractor; Global Biotech Inc., Suzhou, Jiangsu, China). In a dark room, 0.5% Compound Tropicamide Eye Drops (Santen Pharmaceutical (China) Co., Ltd., Suzhou, Jiangsu, China) were administered to both eyes of the guinea pigs for mydriasis four times at 5-min intervals to paralyze the ciliary muscle. After 30 min of dark adaptation, by which time the pupils had become fully dilated, the refractive status of guinea pig eyeballs was determined using an infrared eccentric refractometer, with three measurements being performed for each eye and average values recorded.

2.5 Animal Euthanasia

Euthanasia was performed via an anesthetic overdose. Guinea pigs were placed in an induction chamber and anesthetized with 5% isoflurane in oxygen until losing consciousness. A deep plane of anesthesia was confirmed by the absence of a response to a firm toe pinch. Subsequently, euthanasia was achieved by the intraperitoneal administration of pentobarbital sodium (150 mg/kg) at a concentration of 30 mg/mL (3%) or continuous exposure to 5% isoflurane for at least 10 min after a cessation of breathing. Death was confirmed by the absence of spontaneous respiration, loss of the corneal reflex, or asystole upon cardiac monitoring.

2.6 Histopathological Examination (H&E)

To assess pathological scleral changes in response to form deprivation, we performed staining using hematoxylin and eosin (H&E). On the 42nd day of the experiment, the guinea pigs had been rendered unconscious, and having immediately excised the eyeballs, these were fixed in FAS fixative (Servicebio, Proteintech, Wuhan, Hubei, China) for 48 h. The fixed tissues were paraffin-embedded, serially sectioned (4 µm), deparaffinized with xylene, and stained with H&E for pathological evaluation.

2.7 Transmission Electron Microscopy (TEM)

To assess the morphology of mitochondria in scleral tissue, we performed transmission electron microscopy (TEM). Scleral tissue were fixed in 2.5% glutaraldehyde for 18–20 h, followed by fixation with 1% osmium tetroxide fixation for 1 hour dehydration, and embedding in epoxy resin. Ultra-thin sections (60 nm thick) were cut, stained with 2% uranyl acetate and lead citrate, and examined using a transmission electron microscope (Hitachi, Minato-ku, Tokyo, Japan).

2.8 Immunofluorescence (IF) Analysis

To assess changes in the expression of molecular markers associated with mitochondrial division, we conducted immunofluorescence (IF) analysis. Eye tissue sections (prepared as described) were blocked with 10% goat serum (50 min, room temperature), and incubated overnight at 4 °C with rabbit anti-DRP1 primary antibody (1:250 dilution: 12957-1-AP, Proteintech, China). Following incubation, the sections were treated with peroxidase-conjugated secondary antibodies (1 h at room temperature) for complete immunolabeling.

2.9 Human Scleral Fibroblast Cell (HSFs) Culture

Human scleral fibroblast (HSFs) were obtained from Guangzhou Keyun Selection Biotechnology Co., Ltd. (Guangzhou, China) and cultured in DMEM (Gibco, Grand Island, NY, USA) supplemented with 10% FBS (A5669701, Gibco) and 1% penicillin-streptomycin (Gibco) at 37 °C with 5% CO2. Logarithmic-phase cells (passages 3–4) were used for subsequent experiments. The cell line used was validated based on STR profiling and tested negative for Mycoplasma.

2.10 Induction of Cellular Hypoxia

Cells at 70%–80% confluence were exposed to hypoxic conditions for 24 consecutive hours in sealed culture bags (Cat. No. C-41, Chiyoda-ku, Tokyo, Japan) with Mitsubishi anaerobic gas-generating packs (cat. No. C-11; Japan) to ensure that oxygen concentrations within the bags were maintained at a level below 1%. An anaerobic indicator (Cat. No. C-22, Japan) was used to monitor the oxygen concentration, with the colorimetric criteria defined as pink for <0.1% O2, blue for >0.5% O2, and bluish-purple for an indeterminate intermediate range.

2.11 Cell Counting Kit-8 (CCK-8)

Cells were seeded at an appropriate density in the wells of 96-well plates. Upon reaching 70% to 80% confluence, the cell were pre-treated with different concentrations of Mdivi-1 (cat. No.: HY-15767; MCE, Monmouth Junction, NJ, USA). A 1 mM stock solution of Mdivi-1 in dimethyl sulfoxide (DMSO) was stored at –20 °C and serially diluted in medium to final concentrations of 1, 5, 10, and 15 µM. As a solvent control, we used DMSO at a final concentration 0.1% to avoid solvent interference (Supplementary Fig. 1F). After pre-treatment, the plates were subjected to hypoxia for 12, 24, 36, or 48 h in sealed bags containing hypoxic gas generation packs (Supplementary Fig. 1A). At the selected time points, the medium was replaced with CCK-8-containing fresh medium (Cat. No.: CA1210; Solarbio, Beijing, China), and after incubating for 2 h, absorbances were measured at 450 nm using an INFINITE M200 microplate reader (Model) to assess cell viability under different Mdivi-1 concentrations and hypoxic durations.

2.12 Plasmid Transfection

For short-hairpin RNA (shRNA) treatment, HSFs at 60%–70% confluence were transfected using FectoGene 100 (Beyonpop, Tianjin, China) per manufacturer’s instructions. shRNAs included shHIF-1α (targeting human HIF-1α), shNotch1 (targeting Notch1), and negative control shNC. At 48 h post-transfection, cells were treated as designed, samples collected, and HIF-1α/Notch1 expression determined via quantitative Real-time polymerase chain reaction (qPCR) to validate the efficiency of knockdown (Supplementary Fig. 1B,C).

2.13 Western Blot

HSFs were lysed (20 min) in RIPA buffer (R0010, Solarbio) containing 100 mM phenmethylsulfonyl fluoride (P0100-01; Solarbio), a phosphatase inhibitor (100×: P8991; Solarbio), and a protease inhibitor (100×: P6370; Solarbio). The resulting lysates were centrifuged (12,000 ×g, 20 min, 4 °C), and the concentrations of proteins was quantified using a BCA kit (PC0020; Solarbio). Equal amounts of proteins (20–30 µg) were run on 10% SDS-PAGE gels, with the separated proteins subsequently being transferred to 0.45 µm PVDF membranes. Following transfer, the membranes were blocked for 30 min in 1× protein-free rapid blocking buffer (PS108P; Epizyme, Cambridge, MA, USA), incubated overnight at 4 °C with primary antibodies, washed, and then incubated for 1 h at room temperature with secondary antibodies. Protein bands were developed using ECL Prime (RPN418-1; Amersham, Little Chalfont, Buckinghamshire, United Kingdom) and quantified using ImageJ software (version 1.54r; National Institutes of Health (NIH), Bethesda, Maryland, USA). The antibodies used in this study are listed in Supplementary Table 1.

2.14 Q-PCR

Total RNA was isolated from HSFs using the EZ-press RNA purification kit (EZBioscience, cat. B0004DP, Roseville, CA, USA), reverse-transcribed into cDNA with the Color Reverse Transcription kit (EZBioscience, CA, USA), and quantified using a Nanodrop2000 spectrophotometer. As a reference gene for normalization of mRNA levels, we used β-actin. The primers used for amplification were synthesized commercially by Sangong Biotechnology (Beijing, China), the sequences of which are listed in Supplementary Table 2.

2.15 Immunofluorescence

Cells were fixed in 4% PFA for 10 min, permeabilized with 0.1% Triton X-100 (T8200, Solarbio) for 10 min, then blocked with 1% BSA (SW3015, Solarbio) + 0.1% Tween-20 (T8220, Solarbio) for 30 min. Cells were incubated overnight at 4 °C with primary antibody (α-SMA, rabbit, 1 µg/mL; ab5694, Cambridge, UK). Having subsequently washed with phosphate-buffered saline, the cells were incubated in the dark for 1 h at room temperature with a fluorescent secondary antibody (gb2AF488, Proteintech Sanying) for 1 h at RT in the dark. Target protein distribution was visualized via Zeiss confocal microscope (LSM800, Oberkochen, Oberkochen, Baden-Württemberg, Germany), and fluorescence intensity was quantified with ImageJ.

2.16 Mitochondrial Morphology Analysis

For mitochondrial morphology analysis, cells were stained with MitoTracker (Thermo Scientific, Waltham, MA, USA) and imaged via confocal microscopy. After selecting cell regions and basic preprocessing, ImageJ was used to calculate mitochondrial morphology parameters (average branch length and standard deviation).

2.17 Determinations of Intracellular ROS

The levels of intracellular ROS were determined using a DCFH-DA fluorescent probe (S0033S; Beyotime, Shanghai, China). Following incubation with 10 µM DCFH-DA, cells were washed three times with serum-free medium to remove residual probe, then counterstained with Hoechst for 1 min. Fluorescence images were obtained using a Zeiss confocal microscope (LSM800, Oberkochen, Germany), and intensity was quantified with ImageJ.

2.18 Measurement of Mitochondrial Membrane Potential (ΔΨm)

HSF mitochondrial membrane potentials (ΔΨm) were determined using JC-1 fluorescent dye (C2003S; Beyotime, China). Cells were incubated in the dark for 30 min at 37 °C with 25 µg/mL JC-1 working solution washed with buffer, and examined using a Zeiss confocal microscope. JC-1 forms either J-aggregates (red fluorescence, indicating high mitochondrial membrane potential) or J-monomers (green fluorescence, indicating low mitochondrial membrane potential), with the red/green fluorescence ratio quantified using ImageJ being used to assess ΔΨm.

2.19 Statistical Analysis

All statistical analyses were performed using GraphPad Prism software (version 9.0; GraphPad Software, USA). The normality of data distribution was initially assessed using the Shapiro–Wilk test. For comparisons between two groups, we used an unpaired two-tailed Student’s t-test. Comparisons among three or more groups were conducted using a one-way analysis of variance (ANOVA), followed by appropriate post hoc tests, as indicated in the respective figure legends. Unless otherwise specified, data are presented as the means ± SEM. The threshold for statistical significance was set at a two-sided p-value of <0.05. The levels of significance are denoted as ns (not significant), *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001. The exact sample size (n) for each experiment, which indicated the number of biological replicates, is shown in the corresponding figure legends. All experiments were independently repeated at least three times to ensure reproducibility.

3. Results
3.1 Mitochondrial Fission is Active in Myopic Scleral

To investigate changes in scleral mitochondria during myopic progression, we successfully established an FDM guinea pig model. Compared with the control group, those in the FDM group were found to be characterized by pronounced myopia-associated symptoms, including an elongated axial length and a shift in refractive power towards myopia (Fig. 1A,B), along with marked thinning of the scleral tissue and a looser arrangement of collagen fibers (Fig. 1C). Further TEM examination revealed a pronounced fission of mitochondria in the sclera of the FDM group predominantly exhibited an active fission state (Fig. 1D, Supplementary Fig. 1G). Moreover, DRP1 expression was markedly elevated in the FDM group compared to the CON group (Fig. 1E,F). Comparatively, we detected no significant differences between the two groups with respect to levels of the mitochondrial fusion proteins MFN1 and MFN2, are which taken to be representative of the status of mitochondrial fusion. Contrastingly, mRNA expression levels in the FDM group were significantly lower levels of these proteins in FDM group guinea pigs than in the CON group (Fig. 1G), indicating corresponding changes at the transcriptomic level. Collectively, these findings indicate an increase in mitochondrial fission in the sclera of myopia.

Fig. 1.

Scleral hypoxia and Mitochondrial fission are active in Myopia. (A,B) Axial length and refractive error of 3-week-old guinea pigs measured at 0, 2, 4, 6 weeks post-form deprivation (n = 10). (C) H&E staining of scleral tissues after 6 weeks of form deprivation (n = 3), scale bar = 100 µm. (D) Mitochondrial morphology was observed under transmission electron microscopy (TEM) at magnifications of ×20.0 k (scale bar = 500 nm) and ×5.0 k (scale bar = 2 µm), respectively, with the results as follows: (a) In the CON group, intact cristae morphology is observable (red arrows indicate mitochondria); (b) In the FDM group, mitochondrial cristae were almost completely absent, and mitochondria appeared fragmented (red arrows indicate mitochondria, n = 3). (E) Scleral tissues were stained with DRP1 antibody (Alexa Fluor 488, green) to observe DRP1 expression (n = 3), scale bar = 20 µm. (F) Western blot and qPCR were used to analyze the protein and mRNA levels of DRP1 in scleral tissues between CON and FDM groups (n = 3). (G) Western blot was analysis of MFN1, MFN2 in CON/FDM groups (n = 6) and qPCR was analysis of MFN1, MFN2 in CON/FDM groups (n = 3). Bar chart data: mean ± SEM. Significance: ns, not significant, *p < 0.05, **p < 0.01, ****p < 0.0001. Statistics: unpaired two-tailed Student’s t-test (C–G); one-way ANOVA with Tukey’s post hoc test (A,B). H&E, hematoxylin and eosin; CON, control; FDM, form-deprived myopia; DRP1, dynamin-related protein 1; MFN, mitochondrial fusion protein; SEM, Scanning Electron Microscopy; ANOVA, analysis of variance.

3.2 Scleral Hypoxia Activates HIF-1α Promotes Mitochondrial Fission

To establish the potential causes of mitochondrial fragmentation in myopic sclera, we examined the expression of HIF-1α, and accordingly detected the elevated expression of this marker in the FDM (Fig. 2A), indicating the occurrence of hypoxia in scleral tissue during the progression of myopia. Further culture of hypoxic HSFs revealed an increase in the expression of HIF-1α following exposure to hypoxia for 24 h (Fig. 2B, Supplementary Fig. 1E), accompanied by mitochondrial fragmentation (Fig. 2C). Moreover, there was a close correlation between excessive mitochondrial fission and alterations in mitochondrial membrane potential (ΔΨm). Consequently, we employed the JC-1 fluorescent probe to assess ΔΨm. Under hypoxia conditions, we detected markedly elevated levels of intracellular ROS levels were markedly elevated in HSFs (Fig. 2D). Concomitantly, JC-1 predominantly exhibited green fluorescence in these cells (Fig. 2E), a pattern indicative of monomeric JC-1 formation and reflective of a significant reduction in mitochondrial membrane potential (ΔΨm). Moreover, we observed increases in the levels of DRP1 protein, whereas at the protein level, there were no significant differences between MFN1 and MFN2 at the protein level (Fig. 2F). Conversely, at the mRNA level, HSFs exposed to hypoxia were found to be characterized by an elevated expression of DRP1 and reduction in the expression of MFN1 and MFN2 (Fig. 2G). These findings thus indicate that in HSFs, hypoxia induces an excessive DRP1-mediated fission of mitochondria, accompanied by the accumulation of ROS.

Fig. 2.

Activation of HIF-1α and promotion of mitochondrial fission in the effects of scleral hypoxia. (A) Western blot and qPCR were used to analyze the protein and mRNA levels of HIF-1α in scleral tissues between CON and FDM groups (n = 3). (B) Western blot and qPCR were used to analyze the protein and mRNA levels of HIF-1α in HSFs after 24 h of hypoxia (n = 3). (C) HSFs cultured under hypoxia for 24 h; MitoTracker red staining for mitochondria (n = 3), with average branch length analyzed, scale bar = 20 µm or 10 µm. (D) DCFH-DA probe detected ROS content in hypoxic HSFs (n = 5), scale bar = 100 µm. (E) JC-1 staining measured mitochondrial membrane potential in HSFs post-24 h hypoxia (n = 3), scale bar = 100 µm. (F) Western blot analyzed MFN1, MFN2, and DRP1 expression at the protein levels in hypoxic HSFs (n = 3). (G) qPCR analyzed MFN1, MFN2, and DRP1 expression at the mRNA levels in hypoxic HSFs (n = 3). Bar chart data: mean ± SEM. Significance: ns, not significant, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. All data were analyzed via an unpaired two-tailed Student’s t-test. HIF-1α, hypoxia-inducible factor alpha; HSFs, human scleral fibroblasts; DCFH-DA, 2’,7’-dichlorodihydrofluorescein diacetate; ROS, reactive oxygen species; JC-1, 5,5’,6,6’-tetrachloro-1,1’,3,3’-tetraethylbenzimidazolcarbocyanine iodide.

3.3 Scleral Hypoxia Induces an Increase in FMT

To investigate the effects of scleral hypoxia and mitochondrial fission. In the FDM group, we observed significant reductions in the expression of type I collagen, a key component involved in the synthesis of scleral collagen, and corresponding increases in the expression of α-SMA, a marker specific for FMT (Fig. 3A,B). Similarly, in HSFs after 24 hours of hypoxic culture. We also observed a decrease in type I collagen and an increase in α-SMA (Fig. 3C–E). These findings thus provide evidence to indicate that hypoxia induces phenotypic transformation in HSFs and disrupts collagen metabolism, consistent with the elevated levels of FMT detected the myopic sclera.

Fig. 3.

Scleral hypoxia-induced FMT increase. (A) Western blot analysis of Col1α1 and α-SMA in scleral tissues between CON and FDM groups (n = 3). (B) Q-PCR analysis of Col1α1 and α-SMA in scleral tissues between CON and FDM groups (n = 3). (C) Q-PCR analysis of Col1α1 and α-SMA in HSFs after 24 h of hypoxia (n = 3). (D) Western blot detected Col1α1 and α-SMA protein levels in HSFs after 24 h of hypoxia (n = 3). (E) HSFs cultured under hypoxia for 24 h; α-SMA expression visualized by immunofluorescence staining (Alexa Fluor 488, green) (n = 3), scale bar = 50 µm. Bar chart data: mean ± SEM. Significance: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. All data were analyzed via an unpaired two-tailed Student’s t-test. FMT, fibroblast-myofibroblast transition; Col1α1, collagen type I alpha 1 chain; α-SMA, α-smooth muscle actin.

3.4 HIF-1α Regulates Mitochondrial Dynamics via Notch1

The Notch signaling pathway has been established to play a pivotal role in the regulation of mitochondrial dynamics, and we accordingly sought to determine whether Notch1 is implicated in the mitochondrial fission induced by scleral hypoxia. In the FDM group, we detected elevated levels of Notch1 expression (Fig. 4A), and similar increases in Notch1 expression were observed in HSFs exposed to hypoxia (Fig. 4B). Contrastingly, reductions in Notch1 levels were observed following the shRNA transfection-mediated suppression HIF-1α expression (Fig. 4C), thereby providing evidence of an association between HIF-1α and the expression of Notch1. On the basis of these observations, we subsequently sought to assess the role of Notch1 in mitochondrial fission and fusion, and accordingly found that the shRNA-mediated suppression of Notch1 expression was associated with a significant inhibition of DRP1 activity, whereas the levels of MFN1 and MFN2 were markedly increased at both the protein and mRNA levels (Fig. 4D). Concurrently, a shift toward red fluorescence indicated restoration of mitochondrial membrane potential to normal levels (Fig. 4E). These findings thus indicate that scleral hypoxia-induced mitochondrial fission is promoted via a regulation of Notch1 expression.

Fig. 4.

HIF-1α regulates mitochondrial dynamics through Notch1. (A) Western blot and qPCR were used to analyze the protein and mRNA levels of Notch1 in scleral tissues between CON and FDM groups (n = 3). (B) Western blot and qPCR were used to analyze the protein and mRNA levels of Notch1 in HSFs after 24 h of hypoxia (n = 3). (C) Western blot analysis of Notch1 and HIF-1α protein levels in HSFs transfected with sh-NC or shHIF-1α for 48 h (n = 3). (D) Western blot analysis of Notch1, DRP1, MFN1, and MFN2 protein levels in HSFs transfected with sh-NC or sh-Notch1 for 48 h (n = 3). (E) Mitochondrial membrane potential measured via JC-1 staining in HSFs transfected with sh-NC or sh-Notch1 for 48 h (n = 3), scale bar = 100 µm. Bar chart data: mean ± SEM. Significance: ns, not significant, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. All data were analyzed via an unpaired two-tailed Student’s t-test.

3.5 Mdivi-1 Targets DRP1 to Suppress FMT

As an intervention for myopia, to evaluate the therapeutic potential of targeting mitochondrial fission to intervene in myopia, we examined the effects of inhibiting DRP1-dependent mitochondrial fission on extracellular matrix remodeling in HSFs. The results demonstrated that treatment with mitochondrial fission inhibitor 1 (Mdivi-1) restored mitochondrial morphology in HSFs to a typical filamentous network structure (Fig. 5A). Consistently, JC-1 fluorescence staining enhanced red fluorescence, indicating restoration of mitochondrial membrane potential (Fig. 5B). Furthermore, the intracellular levels of ROS showed no significant difference from those detected in the negative control group (Fig. 5C). Further analysis of ECM-associated markers revealed that Mdivi-1 treatment contributed to a significant upregulation of type I collagen expression and markedly suppressed expression of α-SMA compared with the CON group (Fig. 5D,E; Supplementary Fig. 1D). These findings indicate that Mdivi-1 can effectively suppress the trans-differentiation of scleral fibroblasts to myofibroblasts and promote remodeling of the scleral extracellular matrix.

Fig. 5.

Inhibition of mitochondrial fission suppresses FMT. (A) HSFs treated with negative control or Mdivi-1 (15 µM, Supplementary Fig. 1F) under hypoxia for 24 h; mitochondria labeled with MitoTracker Red, with length quantified (n = 3), scale bar = 20 µm or 10 µm. (B) Mitochondrial membrane potential measured via JC-1 staining in HSFs treated with Mdivi-1 (15 µM) under hypoxia for 24 h (n = 4), scale bar = 50 µm. (C) ROS content detected via DCFH-DA labeling in HSFs treated with Mdivi-1 (15 µM 24 h) under hypoxia (n = 3), scale bar = 100 µm. (D) α-SMA expression determined by IF in HSFs treated with Mdivi-1 (15 µM) under hypoxia for 24 h (n = 3), scale bar = 50 µm. (E) Western blot analysis of Col1α1, DRP1, and α-SMA protein levels in HSFs treated with Mdivi-1 (15 µM) under hypoxia for 24 h (Col1α1, n  = 3; DRP1 and α‑SMA, n  = 4). Bar chart data: mean ± SEM. Significance: ns, not significant, *p < 0.05, ***p < 0.001, ****p < 0.0001. Statistics: unpaired two-tailed Student’s t-test (A–D); one-way ANOVA with Tukey’s post hoc test (E). IF, immunofluorescence.

4. Discussion

Pathological remodeling of the sclera, a key structure for axial elongation, serves as a core link in the progression of myopia [10, 11], and the hypoxic microenvironment is considered a key inducer of this process. In this study, we investigated the role of mitochondrial fission in scleral remodeling during the progression of myopia. The results showed that hypoxic conditions in scleral tissue are associated with enhanced DRP1 activity and an increase in mitochondrial fission. Shortened, fragmented mitochondria were observed in scleral fibroblasts cultured under hypoxic conditions. Subsequent mechanistic studies suggested that hypoxia may regulate DRP1 expression, at least in part, through activation of the Notch1 signaling pathway, coinciding with increased in mitochondrial fission and an accumulation of ROS. These cellular changes are consistent with those characterizing the FDM model, in which hypoxic stress is assumed to induce processes associated with scleral extracellular matrix remodeling. Notably, pharmacological intervention using the DRP1 inhibitor Mdivi-1 was found to effectively suppress mitochondrial fission and reduce the expression of markers associated with pathological scleral remodeling. However, the translational potential of targeting mitochondrial fission for the treatment of myopia will require further validation in vivo.

Mitochondria are the core organelles orchestrating cellular energy metabolism, play a crucial role in regulating cell phenotype transformation, signal transduction, and maintaining redox homeostasis [21]. Notably, however, rather than functioning as static structures, the mitochondria maintain a dynamic balance via a continual cycle of fusion and fission, a process referred to as mitochondrial dynamics [22]. Previous studies have confirmed that mitochondrial dynamics play a key role in regulating the phenotype and function of a diverse range of cell types [23]. Qiu YN et al. [24] showed that enhanced mitochondrial fission is essential for the trans-differentiation of hepatic stellate cells to myofibroblasts and that targeted inhibition of mitochondrial fission contributes to a marked inhibition of the progression of liver fibrosis. Similarly, in lung fibrosis models, transforming growth factor-β induces increased mitochondrial fission in lung fibroblasts, promoting their transformation into myofibroblasts [25]. Our findings in the present study indicate that mitochondrial fission may contribute to a regulation of the scleral extracellular matrix in myopia. In myopic sclera, an increase in mitochondrial fission is observed concomitant with a substantial elevation in the expression of α-SMA and heightened degradation of type I collagen fibers, thereby providing evidence of a potential link between abnormal mitochondrial fission and FMT. However, the precise mechanism underlying this process remains unclear. The present in vitro study provides supportive evidence for the association between mitochondrial fission and HSF transdifferentiation under hypoxia conditions.

The findings of a recent study on mitochondrial dynamics have indicated that mitochondrial fission can be classified into two types based on functional differences: peripheral fission and midzone fission [26, 27]. Midzone fission is more common during normal cellular activities, facilitating the even distribution of mitochondria in the cytoplasm and maintaining energy supply, with stable levels of ROS during this process [16]. In contrast, peripheral fission is often triggered by pathological stress, such as hypoxic and oxidative stress [28, 29], and is frequently accompanied by mitochondrial dysfunction and excessive ROS generation [30], which in turn promotes the formation of pathological cellular phenotypes [31]. We hypothesize that both types of fission may coexist in hypoxia-induced HSFs. Midzone fission is posited to be necessary for the distribution of mitochondria to daughter cells during HSF proliferation to support basal metabolic demands, substantially elevated levels of ROS levels under hypoxic conditions would tend to be indicative of the involvement of peripheral fission.

The Notch signaling pathway has been identified as a key regulator of a diverse range of cellular processes, including proliferation, differentiation, and development [32], and the findings of recent studies have indicated that this pathway is also involved in the redistribution of cellular metabolism, thereby influencing cell fate. For example, in microglia, the activation of Notch1 instigates the release of NICD, which subsequently undergoes translocation to the mitochondria in response to hypoxia, and therein promotes an accumulation of ROS [33]. A recent study reported that post-hypoxic activation of glycolysis in scleral tissue from myopic animal models increased Notch1 expression [34]. The present study revealed that the inhibition of Notch1 expression led to a reduction in DRP1 expression, while concurrently increasing the expression of MFN1 and MFN2. This finding indicates that Notch may be involved in regulating mitochondrial fission and fusion processes in HSFs following hypoxia. However, the underlying crosstalk mechanisms, particularly the direct transcriptional or post-translational regulation of DRP1 by Notch, warrant further investigation. Furthermore, Notch1 stability can be modulated by phosphorylation and proteasomal degradation [35]. Future research should investigate whether kinases known to act on NOTCH1 influence its levels in hypoxic HSFs, to determine if increases are solely due to HIF-1α-driven transcription or also involve changes in protein turnover.

In this study, we demonstrated that pharmacological inhibition of DRP1-induced mitochondrial fission can suppress the expression of hypoxia-induced markers of FMT, a process in which ROS have been hypothesized to play a central role, with concentration-dependent effects. Although physiological levels of ROS are implicated in the regulation of cellular trans-differentiation and tissue remodeling [36] by inducing oxidative damage, an excessive accumulation of ROS has been established to disrupt the functional homeostasis of fibroblasts [37]. Furthermore, mitochondrial fission may influence cellular phenotypes by modulating metabolism (e.g., regulating the tricarboxylic acid cycle and oxidative phosphorylation efficiency) or by releasing damage-associated molecular patterns, such as mitochondrial DNA and cytochrome C [38, 39, 40]. However, the specific role of this mechanism in the myopic sclera requires further investigation.

This study has several limitations that should be considered when interpreting the results and that define clear directions for future research. Firstly, although we established an association among hypoxia, Notch1 activation, and mitochondrial fission, the precise molecular interactions and core regulatory nodes involved to be elucidated. Further, studies employing techniques such as chromatin immunoprecipitation and genetic rescue experiments are needed to establish causality within the HIF-1α-Notch1-DRP1 axis. Second, this study primarily inferred mitochondrial functional status based on changes in morphology, membrane potential, and ROS levels, without directly assessing core respiratory functions such as oxygen consumption rate or ATP production. Consequently, the current conclusions are limited to morphology-associated aspects of mitochondrial dynamics and do not comprehensively address alterations in bioenergetic metabolism. Third, the efficacy of targeting this pathway was only explored in vitro using Mdivi-1. Systematic in vivo validation in animal models is essential to assess the therapeutic potential of inhibiting mitochondrial fission or Notch signaling for myopia control. Finally, although our findings provide evidence for the role for mitochondrial dynamics, comprehensive biomechanical and ultrastructural analyses of the sclera are needed to fully characterize the functional outcomes of the observed cellular changes.

5. Conclusions

Collectively, our findings in this study indicate that during the progression of myopia, scleral hypoxia is associated with an activation of the Notch1 pathway and subsequent disruption of mitochondrial dynamics, events that coincide with changes in the markers of FMT and remodeling of the scleral extracellular matrix. These findings provide evidence for a novel conceptual link between mitochondrial dynamics and hypoxic scleral remodeling in myopia, and will provide a valuable basis for further investigations examining the molecular and cellular mechanisms underlying the development of myopia, as well as a rationale for assessing mitochondrial dynamics as a potential target for strategies that could be adopted to control myopia.

Availability of Data and Materials

The datasets used or analyzed during the current study are available from the corresponding authors on reasonable request.

Author Contributions

JS, KW, LLB, and JW designed the experiments. LLB, JW, and SXL carried out the experiments, MZ and SXL analyzed the experimental data, XMZ and PYH prepared the figures and tables, SMP and XHZ conducted the literature search. Funding acquisition, JS, KW; Writing — original draft, LLB, SXL, and KW; Writing — review & editing, JS, KW, and JW. All authors have read and endorsed the final version of the manuscript. All authors contributed to editorial changes in the manuscript. All authors read and approved the final manuscript. All authors have participated sufficiently in the work and agreed to be accountable for all aspects of the work.

Ethics Approval and Consent to Participate

All animal procedures were performed in accordance with the Guide for the Care and Use of Laboratory Animals (8th Edition) published by the National Research Council (US) Institute for Laboratory Animal Research (2011) and approved by the Medical Laboratory Animal Ethics Committee of Tianjin Medical University Eye Hospital (approval No. TJYY2024120244).

Acknowledgment

Thanks to all the peer reviewers for their opinions and suggestions.

Funding

This work was supported by [Tianjin Binhai New Area Health Research Project (Grant No. 2023BWKQ019 and No. 2023BWKZ007); Tianjin Medical University Eye Hospital High-level Innovative Talent Programme (Grant No. YDYYRCXM-E2023-04); and Tianjin Key Medical Discipline Construction Project (Grant No. TJYXZDXK-3-004A-2)].

Conflict of Interest

The authors declare no conflict of interest.

Supplementary Material

Supplementary material associated with this article can be found, in the online version, at https://doi.org/10.31083/FBL49381.

References

Publisher’s Note: IMR Press stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.